You have 9 free searches left this month | for more free features.

Condition

Inflammatory Bowel Diseases (2)

Ankylosing Spondylitis (1)

Crohn's Disease (1)

Psoriatic Arthritis (1)

Rheumatoid Arthritis (1)

Rheumatoid Diseases (1)

Rheumatologic Disease (1)

Ulcerative Colitis (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

Sponsor

Pfizer (2)

IRCCS San Raffaele (1)

Collaborator

Hospira, now a wholly owned subsidiary of Pfizer (2)

Intervention

ct-p13 (3)

remicade (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Observational (3)

ct-p13

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM

Recruiting

Inflammatory Bowel Diseases
Rheumatologic Disease

CT-P13

Milano, Italy

Irccs Ospedale San Raffaele

Jan 30, 2023

CT-P13 For Standard Of Care Treatment Of Rheumatoid Diseases Who

Completed

Has Results

Rheumatoid Diseases
+3 more

CT-P13

Plovdiv, Bulgaria
+37 more

Dec 20, 2019

CT-P13 For Standard Of Care Treatment Of Inflammatory Bowel

Completed

Has Results

Inflammatory Bowel Diseases
+2 more

CT-P13
Remicade

Leuven, Vlaams Brabant, Belgium
+139 more

Jan 30, 2020